O
Orum Therapeutics Inc
KOSDAQ:475830
Orum Therapeutics Inc
KOSDAQ:475830
Price:
86 000
KRW
0.12%
Market Closed
Market Cap:
₩1.8T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Orum Therapeutics Inc
Other Equity
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Orum Therapeutics Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Orum Therapeutics Inc
KOSDAQ:475830
|
Other Equity
₩10.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other Equity
₩533.6B
|
CAGR 3-Years
57%
|
CAGR 5-Years
62%
|
CAGR 10-Years
39%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Other Equity
₩63.1B
|
CAGR 3-Years
85%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other Equity
₩12B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other Equity
₩51.3B
|
CAGR 3-Years
129%
|
CAGR 5-Years
89%
|
CAGR 10-Years
43%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other Equity
₩20.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Orum Therapeutics Inc
Glance View
Orum Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2025-02-14. The firm is principally engaged in the research and development of new biopharmaceuticals for cancer and immune diseases based on its platforms.
Intrinsic Value
800.61
KRW
Overvaluation 99%
O
See Also
What is Orum Therapeutics Inc's Other Equity?
Other Equity
10.3B
KRW
10.3B
KRW
Based on the financial report for Dec 31, 2024, Orum Therapeutics Inc's Other Equity amounts to 10.3B KRW.
What is Orum Therapeutics Inc's Other Equity growth rate?
Other Equity CAGR 1Y
52%
52%
Over the last year, the Other Equity growth was 52%.
